Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study.

Autor: Kattamis A; First Department of Pediatrics Thalassemia Unit National and Kapodistrian University of Athens Athens Greece., Voskaridou E; Expertise Center in Rare Haematological Diseases-Haemoglobinopathies General Hospital of Athens 'Laikon' Athens Greece., Delicou S; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Hippocrateion' Athens Greece., Klironomos E; Thalassemia and Sickle Cell Unit General Hospital of Heraklion 'Venizelion' Heraklion Greece., Lafiatis I; Thalassemia and Sickle Cell Unit General Hospital of Mytilene 'Vostanio' Mytilene Greece., Petropoulou F; Thalassemia Unit General Hospital of Athens 'Georgios Gennimatas' Athens Greece., Diamantidis MD; Thalassemia and Sickle Cell Disease Unit General Hospital of Larissa 'Koutlimbaneio & Triantafylleio' Larissa Greece., Lafioniatis S; Thalassemia and Sickle Cell Unit General Hospital of Volos 'Achilopouleio,' Volos Greece., Evliati L; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Evaggelismos' Athens Greece., Kapsali E; Department of Hematology University Hospital of Ioannina Ioannina Greece., Karvounis-Marolachakis K; Medical Department Genesis Pharma SA Athens Greece., Timotheatou D; Medical Department Genesis Pharma SA Athens Greece., Deligianni C; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Viktoratos P; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Kourakli A; Department of Internal Medicine Hematology Division University General Hospital of Patras Patras Greece.

Publikováno v: EJHaem [EJHaem] 2023 May 23; Vol. 4 (3), pp. 569-581. Date of Electronic Publication: 2023 May 23 (Print Publication: 2023).